Could drugs used after an organ transplant protect against Alzheimer’s?
A Southwestern study in mice provides new clues about how a class of anti-rejection drugs used after organ transplants may also slow the progression of early-stage Alzheimer’s disease. The study was supported by the Senator Betty and Dr. Andy Andujar Endowment and by the NIH. March 20, 2018